Physician

Andrew B Covit, MD

According to 2025 Medicare claims, Andrew Covit, MD (NPI: 1528058922) practices nephrology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 07728-2537.

Covit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 458 traditional Medicare patients, billed 3,410 HCPCS/CPT codes, and received $227,399 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,490 prescription claims across 318 beneficiaries totaling $329,813 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 132 claims. Open Payments data shows 34 records totaling $517. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	760	3,892	$275,448
2016	762	3,514	$226,130
2017	693	3,496	$199,252
2018	635	3,322	$234,297
2019	568	2,648	$212,831
2020	518	2,312	$180,510
2021	510	2,553	$207,017
2022	520	3,052	$200,387
2023	469	3,632	$212,514
2024	458	3,410	$227,399

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	166	1,305	$430,550
2016	182	1,416	$176,226
2017	216	1,579	$167,306
2018	249	1,798	$149,509
2019	269	1,874	$155,549
2020	251	2,108	$203,585
2021	255	2,084	$205,960
2022	255	2,067	$202,313
2023	284	2,284	$267,167
2024	318	2,490	$329,813

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	148	$7,206
2016	N/R	184	$9,377
2017	N/R	196	$8,933
2018	N/R	123	$5,039
2019	N/R	136	$12,087
2020	N/R	29	$529
2021	N/R	88	$2,929
2022	N/R	54	$2,053
2023	N/R	140	$4,405
2024	N/R	132	$4,034

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	52	62	$142
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	86	391	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	335	697	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	45	51	$69
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	70	73	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Veltassa	Patiromer Calcium Sorbitex	49	2,559	$76,744
Farxiga	Dapagliflozin Propanediol	49	2,600	$46,407
Lokelma	Sodium Zirconium Cyclosilicate	17	1,283	$25,977
Clinolipid	Fat Emulsion/Olive/Soy/Phospho	66	456	$13,327
Eliquis	Apixaban	16	660	$12,058

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	13	$1,190
J7502	Cyclosporine, oral, 100 mg	N	N/R	11	$1,076
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	39	$865
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	23	$369
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	20	$358

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$517	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew B. Covit, MD?

Tedicare shows public-source Medicare data for Andrew B. Covit, MD (NPI 1528058922), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew B. Covit, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew B. Covit, MD?

Andrew B. Covit, MD is linked to HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (billing NPI 1215989249) in the available physician profile data.

Does Andrew B. Covit, MD have Open Payments data?

Andrew B. Covit, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.